These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 5507691)

  • 1. The influence of oximes on the distribution of 32P in the body of the rat after injection of 32P-sarin.
    Polak RL; Cohen EM
    Biochem Pharmacol; 1970 Mar; 19(3):865-76. PubMed ID: 5507691
    [No Abstract]   [Full Text] [Related]  

  • 2. The binding of sarin in the blood plasma of the rat.
    Polak RL; Cohen EM
    Biochem Pharmacol; 1970 Mar; 19(3):877-81. PubMed ID: 5507692
    [No Abstract]   [Full Text] [Related]  

  • 3. Distribution of DF32P in mouse organs. II. The effect of prophylactically administered oximes and atropine on incorporation and toxicity.
    Ramachandran BV
    Biochem Pharmacol; 1966 Oct; 15(10):1577-87. PubMed ID: 5971810
    [No Abstract]   [Full Text] [Related]  

  • 4. The influence of triorthocresylphosphate on the distribution of 32P in the body of the rat after the injection of 32P-sarin.
    Polak RL; Cohen EM
    Biochem Pharmacol; 1969 Apr; 18(4):813-20. PubMed ID: 5788520
    [No Abstract]   [Full Text] [Related]  

  • 5. In vitro reactivation of sarin-inhibited brain acetylcholinesterase from different species by various oximes.
    Kuca K; Cabal J; Kassa J
    J Enzyme Inhib Med Chem; 2005 Jun; 20(3):227-32. PubMed ID: 16119192
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A comparison of the efficacy of a bispyridinium oxime--1,4-bis-(2-hydroxyiminomethylpyridinium) butane dibromide and currently used oximes to reactivate sarin, tabun or cyclosarin-inhibited acetylcholinesterase by in vitro methods.
    Kuca K; Cabal J; Kassa J
    Pharmazie; 2004 Oct; 59(10):795-8. PubMed ID: 15544060
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of K074 and pralidoxime on antioxidant and acetylcholinesterase response in malathion-poisoned mice.
    dos Santos AA; dos Santos DB; Ribeiro RP; Colle D; Peres KC; Hermes J; Barbosa AM; Dafré AL; de Bem AF; Kuca K; Farina M
    Neurotoxicology; 2011 Dec; 32(6):888-95. PubMed ID: 21723318
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of in vitro potency of oximes (pralidoxime, obidoxime, HI-6) to reactivate sarin-inhibited acetylcholinesterase in various parts of pig brain.
    Kuca K; Cabal J; Kassa J; Jun D; Hrabinová M
    J Appl Toxicol; 2005; 25(4):271-6. PubMed ID: 16021679
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Passage of tertiary and quaternary nitrogen compounds through the rat placenta.
    Andersen RA; Barstad JA
    Arch Int Pharmacodyn Ther; 1974 Aug; 210(2):232-40. PubMed ID: 4613292
    [No Abstract]   [Full Text] [Related]  

  • 10. The effect of oximes on isolated organs intoxicated with organophosphorus anticholinesterases.
    van der Meer C; Wolthuis OL
    Biochem Pharmacol; 1965 Sep; 14(9):1299-312. PubMed ID: 5857534
    [No Abstract]   [Full Text] [Related]  

  • 11. A comparison of the potency of the oxime HLö-7 and currently used oximes (HI-6, pralidoxime, obidoxime) to reactivate nerve agent-inhibited rat brain acetylcholinesterase by in vitro methods.
    Kuca K; Cabal J; Kassa J; Jun D; Hrabinová M
    Acta Medica (Hradec Kralove); 2005; 48(2):81-6. PubMed ID: 16259317
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phosphylated oximes. Some pharmaco-toxicological and biochemical features.
    Barstad JA; Lilleheil G; Skobba TJ
    Arch Int Pharmacodyn Ther; 1969 Jun; 179(2):352-63. PubMed ID: 5367309
    [No Abstract]   [Full Text] [Related]  

  • 13. Potency of five structurally different acetylcholinesterase reactivators to reactivate human brain cholinesterases inhibited by cyclosarin.
    Kuca K; Cabal J; Jun D; Hrabinova M
    Clin Toxicol (Phila); 2007; 45(5):512-5. PubMed ID: 17503257
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The influence of DFP, atropine and pyridinium aldoximes on the rate of clearance of diisopropyl phosphate (DI32P) from the mouse circulatory system.
    Ramachandran BV
    Biochem Pharmacol; 1967 Nov; 16(11):2061-8. PubMed ID: 4229543
    [No Abstract]   [Full Text] [Related]  

  • 15. A comparison of the potency of newly developed oximes (K005, K027, K033, K048) and currently used oximes (pralidoxime, obidoxime, HI-6) to reactivate sarin-inhibited rat brain acetylcholinesterase by in vitro methods.
    Kuca K; Cabal J; Kassa J
    J Toxicol Environ Health A; 2005 Apr; 68(8):677-86. PubMed ID: 15901095
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of DFP and obidoxime on brain acetylcholine levels on brain and peripheral cholinesterases.
    Mayer O; Michalek H
    Biochem Pharmacol; 1971 Nov; 20(11):3029-37. PubMed ID: 4943596
    [No Abstract]   [Full Text] [Related]  

  • 17. In vitro potency of H oximes (HI-6, HLö-7), the oxime BI-6, and currently used oximes (pralidoxime, obidoxime, trimedoxime) to reactivate nerve agent-inhibited rat brain acetylcholinesterase.
    Kuca K; Cabal J; Kassa J; Jun D; Hrabinova M
    J Toxicol Environ Health A; 2006 Aug; 69(15):1431-40. PubMed ID: 16766478
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oximes and atropine in sarin poisoning.
    ASKEW BM
    Br J Pharmacol Chemother; 1957 Sep; 12(3):340-3. PubMed ID: 13460241
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Potency of new structurally different oximes to reactivate cyclosarin-inhibited human brain acetylcholinesterases.
    Kuca K; Cabal J; Jun D; Bajgar J; Hrabinova M
    J Enzyme Inhib Med Chem; 2006 Dec; 21(6):663-6. PubMed ID: 17252938
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protective effects of oximes HI-6 and PAM-2 applied by osmotic minipumps in quinalphos-poisoned rats.
    Bokonjić D; Jovanović D; Jokanović M; Maksimović M
    Arch Int Pharmacodyn Ther; 1987 Aug; 288(2):309-18. PubMed ID: 3675088
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.